ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
152 hedge funds and large institutions have $489M invested in iTeos Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 57 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $704M → $489M (-$215M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
66% less call options, than puts
Call options by funds: $322K | Put options by funds: $948K
Holders
152
Holding in Top 10
2
Calls
$322K
Puts
$948K
Top Buyers
| 1 | +$4.49M | |
| 2 | +$3.41M | |
| 3 | +$2.06M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$1.89M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.23M |
Top Sellers
| 1 | -$4.71M | |
| 2 | -$4.29M | |
| 3 | -$3.86M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.94M |
| 5 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$1.69M |